Cellmotions is developing a full line of bioreactors incorporating the Bach impeller technology. The bioreactors will be available in varying sizes designed to meet the needs of researchers and those seeking to generate initial production volumes. In keeping with industry trends, the bioreactor vessels housing the Bach impeller will be instrumented single use units.
The products will be third party manufactured in North America and will meet all applicable industry standards. They will be available for purchase directly through Cellmotions and its distribution network.